PMID: 11911758Mar 26, 2002Paper

Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women

JAMA : the Journal of the American Medical Association
Andrew R Wiesen, Christopher T Littell

Abstract

Substantial concern surrounds the potential health effects of the anthrax vaccine, particularly the potential adverse effects on reproductive processes. To determine whether receipt of anthrax vaccination by reproductive-aged women has an effect on pregnancy rates. Cohort study, based on information from a computer database, of women aged 17 to 44 years who were stationed at Fort Stewart, Ga, or Hunter Army Airfield, Ga, from January 1999 through March 2000. Pregnancy and birth rates and adverse birth outcomes. Of a total of 4092 women, 3136 received at least 1 dose of the anthrax vaccine. There was a total of 513 pregnancies, with 385 following at least 1 dose of anthrax vaccine. The pregnancy rate ratio (before and after adjustment for marital status, race, and age) comparing vaccinated with unvaccinated women was 0.94 (95% confidence interval [CI], 0.8-1.2; P =.60). There were 353 live births and 25 pregnancies lost to follow-up. The birth odds ratio after anthrax vaccination (before and after adjustment for marital status and age) was 0.9 (95% CI, 0.5-1.4; P =.55). After adjusting for age, the odds ratio for adverse birth outcome after receiving at least 1 dose of anthrax vaccination was 0.9 (95% CI, 0.4-2.4; P =.88). Howev...Continue Reading

Citations

Mar 1, 2007·Women's Health·Flor M Munoz
Apr 9, 2008·Emerging Infectious Diseases·Eric Jacob SternNancy Messonnier
Jul 5, 2008·American Journal of Epidemiology·Margaret A K RyanJ David Erickson
Apr 20, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Morad HassaniLiise-Anne Pirofski
Nov 15, 2007·Journal of Occupational and Environmental Medicine·Jill DowningJohn D Grabenstein
Jul 19, 2002·Prenatal Diagnosis
Oct 14, 2004·The Journal of Perinatal & Neonatal Nursing·Jackie Tillett
Dec 5, 2002·Pharmacoepidemiology and Drug Safety·J D Grabenstein
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John D Grabenstein
Jun 28, 2011·Vaccine·Sandra I SulskyPaul J Amoroso
Sep 2, 2008·Travel Medicine and Infectious Disease·I Dale Carroll, Damian C Williams
Sep 1, 2009·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Cynthia FrancoA Thomas Waytes
Jun 7, 2005·Advanced Drug Delivery Reviews·Robert N Brey
Feb 3, 2004·Immunology and Allergy Clinics of North America·John D Grabenstein
May 30, 2006·American Journal of Obstetrics and Gynecology·Denise J JamiesonTracee A Treadwell
Aug 10, 2012·Vaccine·Sandra I SulskyPaul J Amoroso
Mar 5, 2016·Expert Review of Vaccines·Jarad M SchifferConrad P Quinn
Mar 10, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R Scott BraithwaiteMark S Roberts
Aug 22, 2003·Journal of the Royal Army Medical Corps·Guy Vautier
Jun 27, 2020·Seminars in Reproductive Medicine·Kathryn MezwaGlenn Markenson
Aug 30, 2021·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Stacey E IobstLori L Trego

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

© 2022 Meta ULC. All rights reserved